A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07693738 · RECRUITING
Trial details
- NCT number
- NCT07693738
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-18
- Primary completion
- 2027-08-29
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.